Citi Keeps Their Hold Rating on Moderna (MRNA) - Markets Insider

Retrieved on: 2025-03-27 18:18:59

Tags for this article:

Click the tags to see associated articles and topics

Citi Keeps Their Hold Rating on Moderna (MRNA) - Markets Insider. View article details on hiswai:

Excerpt

Citi analyst Geoff Meacham reiterated a Hold rating on Moderna (MRNA – Research Report) yesterday and set a price target of $40.00. The company'.

Article found on: markets.businessinsider.com